megestrol acetate has been researched along with Wasting Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Logomarsino, JV; Smith, CS | 1 |
| Giles-Smith, L; Nadurak, S; Orsulak, C; Tangri, N; Wazny, LD | 1 |
| Blaszczyk, AT; Fox, CB; Sleeper, RB; Treadway, AK | 1 |
| Gullett, NP; Hebbar, G; Ziegler, TR | 1 |
| Antonietti, C; Gilli, G; Lelli, G; Montanari, M; Scapoli, D | 1 |
| Deutsch, J; Kolhouse, JF | 1 |
| Bushey, TI; Christensen, B; Dakhil, SR; Gagnon, B; Jatoi, A; Loprinzi, CL; MacDonald, N; Mailliard, JA; Nair, S; Novotny, PJ; Rowland, K; Sloan, JA | 1 |
| Dahele, M; Wall, L | 1 |
| Davis, MP | 1 |
| Chidakel, AR; Fleckman, AM; Homel, P; Schappert, JW; Schlosser, JR; Zweig, SB | 1 |
| Ghiani, M; Lai, P; Macciò, A; Mantovani, G; Massa, E; Santona, MC | 1 |
| Mann, M | 1 |
| Elovic, E | 1 |
| Levine, DM; Olson, JS; Parker, TS; Schuster, MW; Stevens, MR; Wu, SY; Yeh, S | 1 |
7 review(s) available for megestrol acetate and Wasting Disease
| Article | Year |
|---|---|
Using megestrol acetate to ameliorate protein-energy wasting in chronic kidney disease.
Topics: Appetite Stimulants; Humans; Megestrol Acetate; Protein-Energy Malnutrition; Renal Insufficiency, Chronic; Wasting Syndrome | 2016 |
The Efficacy and Safety of Megestrol Acetate in Protein-Energy Wasting due to Chronic Kidney Disease: A Systematic Review.
Topics: Appetite; Appetite Stimulants; Body Weight; Humans; Megestrol Acetate; Nutritional Status; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Treatment Outcome; Wasting Syndrome; Weight Gain | 2016 |
Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
Topics: Aged; Antidepressive Agents, Tricyclic; Appetite Stimulants; Cachexia; Case-Control Studies; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Megestrol Acetate; Mianserin; Mirtazapine; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Wasting Syndrome; Weight Loss | 2009 |
Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting.
Topics: Anabolic Agents; Cachexia; Clinical Trials as Topic; Ghrelin; Human Growth Hormone; Humans; Megestrol Acetate; Muscular Atrophy; Oxandrolone; Steroids; Testosterone; Wasting Syndrome | 2010 |
Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal.
Topics: Anorexia; Cachexia; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Metoclopramide; Neoplasms; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Terminally Ill; Treatment Outcome; Wasting Syndrome | 2003 |
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Topics: Anorexia; Appetite Stimulants; Cachexia; Cytokines; Humans; Interleukin-1; Interleukin-6; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasms; Progesterone Congeners; Tumor Necrosis Factor-alpha; Wasting Syndrome | 1998 |
Pharmacological therapeutics in nutritional management.
Topics: Anabolic Agents; Anorexia; Appetite Regulation; Brain Injuries; Dronabinol; Humans; Megestrol Acetate; Progesterone; Psychotropic Drugs; Wasting Syndrome | 2000 |
4 trial(s) available for megestrol acetate and Wasting Disease
| Article | Year |
|---|---|
Assessment of gastrointestinal function and response to megesterol acetate in subjects with gastrointestinal cancers and weight loss.
Topics: Adult; Aged; Appetite Stimulants; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Humans; Male; Megestrol Acetate; Middle Aged; Nutritional Status; Prospective Studies; Time Factors; Treatment Outcome; Wasting Syndrome; Weight Gain; Weight Loss | 2004 |
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Topics: Aged; Appetite; Appetite Stimulants; Body Weight; Canada; Dietary Supplements; Eicosapentaenoic Acid; Female; Humans; Male; Megestrol Acetate; Middle Aged; Neoplasms; Quality of Life; Survival Rate; Wasting Syndrome | 2004 |
High prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetate.
Topics: Adrenal Insufficiency; Aged; Aged, 80 and over; Appetite Stimulants; Cross-Sectional Studies; Female; Humans; Hydrocortisone; Male; Megestrol Acetate; Middle Aged; Wasting Syndrome | 2006 |
Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome.
Topics: Aged; Appetite; Cytokines; Double-Blind Method; Female; Humans; Male; Megestrol Acetate; Nursing Homes; Nutritional Status; Prospective Studies; Quality of Life; Statistics as Topic; Wasting Syndrome; Weight Gain | 2000 |
3 other study(ies) available for megestrol acetate and Wasting Disease
| Article | Year |
|---|---|
Optimizing end points and outcomes in cancer-associated wasting.
Topics: Appetite; Appetite Stimulants; Eicosapentaenoic Acid; Endpoint Determination; Humans; Megestrol Acetate; Neoplasms; Reproducibility of Results; Wasting Syndrome; Weight Gain | 2005 |
Eicosapentaenoic acid: the answers are not all in.
Topics: Appetite; Eicosapentaenoic Acid; Humans; Megestrol Acetate; Neoplasms; Wasting Syndrome | 2005 |
Approved pharmacologic interventions for wasting: an overview and lessons learned.
Topics: Anabolic Agents; Appetite Stimulants; Clinical Trials as Topic; Dronabinol; Human Growth Hormone; Humans; Megestrol Acetate; Oxandrolone; Wasting Syndrome | 1999 |